Product Profile

Beclomethasone + Phenylephrine + Lignocaine Cream is a specialized four-active anorectal prescription cream combining a corticosteroid, vasoconstrictor, local anaesthetic, and antimicrobial preservative to address inflammation, swelling, pain, and congestion simultaneously. As a premier WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech manufactures this complex multi-active topical using controlled semi-solid homogenization, ensuring that each of the four APIs is uniformly distributed and chemically stable in every 20gm tube.

Manufacturing Advantage

Why Saar Biotech for Beclomethasone + Phenylephrine + Lignocaine Cream?

Since 2005, Saar Biotech has been a distinguished WHO-GMP certified leader in pharmaceutical manufacturing. We utilize advanced micronization and pH-stabilization protocols to deliver unmatched bioavailability for this Beclomethasone + Phenylephrine + Lignocaine Cream formulation.

DCGI Approved

Comprehensive documentation and CDSCO support for rapid market entry in India.

Fast Turnaround

30-45 days lead time for new batches with state-of-the-art logistics.

Pan-India Supply & Contract Manufacturing

Batch Lead Time 30-45 Days (Domestic)
B2B Services Contract & Third-Party
Compliance DCGI & Schedule M Standards
Medical Intelligence

Clinical Q&A for Beclomethasone + Phenylephrine + Lignocaine Cream

Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.

What are the primary clinical indications for Beclomethasone + Phenylephrine + Lignocaine Cream?

This four-component topical cream is formulated for the symptomatic relief of anorectal conditions including haemorrhoids (piles), anal fissures, and pruritus ani — where inflammation, mucosal swelling, vascular congestion, and local pain all require concurrent management. Beclomethasone provides anti-inflammatory corticosteroid action, phenylephrine reduces vascular congestion via vasoconstriction, lignocaine delivers rapid local anaesthetic relief, and chlorocresol acts as an antimicrobial preservative. Final prescribing must follow approved indications and physician direction.

How do all four active components work together in this formulation?

Beclomethasone Dipropionate (0.025% w/w) is a topical glucocorticoid that suppresses the release of pro-inflammatory cytokines and reduces mucosal oedema by inhibiting the arachidonic acid cascade. Phenylephrine Hydrochloride (0.10% w/w) is an alpha-1 adrenergic agonist that causes vasoconstriction in local haemorrhoidal plexuses, reducing engorgement and swelling. Lignocaine Hydrochloride (2.50% w/w) reversibly blocks voltage-gated sodium channels in sensory nerve fibres, producing rapid but temporary local anaesthesia and itch relief within 5 to 10 minutes of application. Chlorocresol (0.1% w/w) serves as the preservative, maintaining the microbiological integrity of the cream throughout its shelf life.

What is the standard dosing protocol for this anorectal cream?

A small quantity of cream should be applied to the affected perianal area and/or gently inserted into the anal canal using a clean applicator or finger, one to three times daily — typically morning, evening, and after each bowel movement. The duration of use should be limited to the shortest period consistent with symptom control, generally not exceeding two weeks of continuous use, to minimize corticosteroid-related local side effects. A physician must supervise extended treatment courses.

What precautions apply to topical corticosteroid-containing anorectal creams?

Prolonged application of topical corticosteroids to perianal or perirectal areas should be avoided due to risks of local skin atrophy, striae, and — on thin or damaged mucosal surfaces — increased systemic absorption. Lignocaine in high concentrations can cause systemic cardiovascular effects if applied to large mucosal surfaces or damaged skin; adherence to the recommended application quantity is essential. This cream should not be used in the presence of active viral, bacterial, or fungal anorectal infections unless these are concurrently treated.

What are the common side effects and when should the patient seek medical advice?

Local side effects may include temporary burning or stinging upon initial application, mild erythema, or perianal irritation — usually transient and self-resolving. With prolonged use, skin thinning or hypopigmentation may develop around the application site. Systemic lignocaine effects (dizziness, tinnitus, circumoral numbness) are rare at the applied concentration but warrant immediate medical review if suspected. Patients should consult a physician if no improvement is evident within seven days, if bleeding worsens, or if severe pain develops.
Manufacturing Support

B2B Manufacturing Guide for Beclomethasone + Phenylephrine + Lignocaine Cream

Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.

What pack size and packaging format is available for Beclomethasone + Phenylephrine + Lignocaine Cream contract manufacturing?
Saar Biotech manufactures this anorectal cream in 20gm laminated tube format as confirmed from our production data. Packaging options include sticker-label laminated tubes, printed tubes with brand embossing, drip-off mono-cartons, and premium carton finishes. An applicator can be included in the carton for brands positioning the product for internal anorectal application. Custom leaflet inserts with Schedule M-compliant prescribing information are also supported.
What is the MOQ for Beclomethasone + Phenylephrine + Lignocaine Cream manufacturing?
Commercial MOQ for this four-active cream typically starts at 5,000 tubes and scales to 2,00,000+ units per batch depending on artwork finalisation, raw material lead times, and packaging configuration. New brands entering the anorectal segment can opt for brand-entry volumes to test market response before committing to larger commercial runs.
What analytical tests are performed on every batch of this cream?
Every commercial batch undergoes individual HPLC Assay for all active components — Beclomethasone Dipropionate, Phenylephrine Hydrochloride, and Lignocaine Hydrochloride — confirming 100% label claim accuracy against IP reference standards. Additional release tests include pH, viscosity, appearance, microbial limit testing (MLT), net content per tube, and pack integrity verification. A complete Certificate of Analysis (COA) is issued with every B2B dispatch.
Can Saar Biotech support brand name registration and DCGI product filing for this cream?
Yes. Our regulatory support team assists B2B manufacturing partners with DCGI brand name search, product registration documentation, and Schedule M artwork compliance for multi-active anorectal and topical prescription creams. We ensure all required drug concentration disclosures, external/anorectal use cautions, and prescription-only warnings are correctly integrated into the artwork before production begins.
What packaging and carton design support is available for private-label manufacturing?
Saar Biotech’s packaging coordination team provides comprehensive design support for private-label brands. Available options include printed laminated tubes, brand-embossed drip-off mono-cartons with UV spot finish, premium metallic cartons, applicator inclusion, and full-colour outer shipper customization. All artwork undergoes a Schedule M labelling compliance review before final approval to production.
What is the manufacturing turnaround time for a new Beclomethasone + Phenylephrine + Lignocaine Cream order?
A new third-party manufacturing order for this cream is typically dispatched within 30 to 45 working days from artwork sign-off and raw material availability confirmation at our Baddi facility. Established brand partners placing repeat commercial batches benefit from pre-validated formulation records and stored artwork approvals, reducing turnaround to 20 to 25 working days. Rush production slots can be discussed for urgent market launch requirements.
Call Us
WhatsApp
Email